Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Leukemia, Myeloid, Acute 22Myelodysplastic Syndromes 18Precursor Cell Lymphoblastic Leukemia-Lymphoma 13Lymphoma 12Leukemia 10Multiple Myeloma 9Hodgkin Disease 9Neuroblastoma 8Sarcoma 7Lymphoma, Non-Hodgkin 6Sarcoma, Ewing 5Primary Myelofibrosis 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Neoplasms, Plasma Cell 5Leukemia, Lymphocytic, Chronic, B-Cell 5Wilms Tumor 4Rhabdomyosarcoma 4Neuroectodermal Tumors, Primitive, Peripheral 4Medulloblastoma 4Lymphoma, Large B-Cell, Diffuse 4Leukemia, Myelomonocytic, Chronic 4Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Hematologic Neoplasms 4Graft vs Host Disease 4Congenital Abnormalities 4Central Nervous System Neoplasms 4Astrocytoma 4Testicular Neoplasms 3Retinoblastoma 3Optic Nerve Glioma 3

Interventions

Irinotecan 6Cyclophosphamide 3temsirolimus 2Sirolimus 2Filgrastim 2Carboplatin 2sargramostim 1reolysin 1irofulven 1cixutumumab 1aflibercept 1Vincristine 1Trabectedin 1Topotecan 1Tirapazamine 1Thiotepa 1Temozolomide 1Peripheral Blood Stem Cell Transplantation 1Pemetrexed 1Oxaliplatin 1Methylprednisolone 1Melphalan 1Immunologic Techniques 1Immunohistochemistry 1Gemcitabine 1Gefitinib 1Flow Cytometry 1Etoposide 1Enzyme-Linked Immunosorbent Assay 1Cyclosporine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Unspecified Childhood Solid Tumor, Protocol Specific × Busulfan × Clear all
NCT00436761 2013-12-18

Busulfan, Melphalan, and Antithymocyte Globulin Followed By Umbilical Cord Blood Transplant in Treating Young Patients With Refractory or Relapsed Malignant Solid Tumors

National Cancer Institute (NCI)

Phase 1 Unknown
20 enrolled
Other solid neoplasm

Unspecified Childhood Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡